Abstract:Clostridium difficile is an opportunistic pathogen inhabiting the human gut, often being the aetiological agent of infections after a microbiota dysbiosis following, for example, an antibiotic treatment. C. difficile infections (CDI) constitute a growing health problem with increasing rates of morbidity and mortality at groups of risk, such as elderly and hospitalized patients, but also in populations traditionally considered low-risk. This could be related to the occurrence of virulent strains which, among other factors, have high-level of resistance to fluoroquinolones, more efficient sporulation and markedly high toxin production. Several novel intervention strategies against CDI are currently under study, such as the use of probiotics to counteract the growth and/or toxigenic activity of C. difficile. In this work, we have analyzed the capability of twenty Bifidobacterium and Lactobacillus strains, from human intestinal origin, to counteract the toxic effect of C. difficile LMG21717 upon the human intestinal epithelial cell line HT29. For this purpose, we incubated the bacteria together with toxigenic supernatants obtained from C. difficile. After this co-incubation new supernatants were collected in order to quantify the remnant A and B toxins, as well as to determine their residual toxic effect upon HT29 monolayers. To this end, the real time cell analyser (RTCA) model, recently developed in our group to monitor C. difficile toxic effect, was used. Results obtained showed that strains of Bifidobacterium longum and B. breve were able to reduce the toxic effect of the pathogen upon HT29, the RTCA normalized cell-index values being inversely correlated with the amount of remnant toxin in the supernatant. The strain B. longum IPLA20022 showed the highest ability to counteract the cytotoxic effect of C. difficile acting directly against the toxin, also having the highest capability for removing the toxins from the clostridial toxigenic supernatant. Image analysis showed that this strain prevents HT29 cell rounding; this was achieved by preserving the F-actin microstructure and tight-junctions between adjacent cells, thus keeping the typical epithelium-like morphology. Besides, preliminary evidence showed that the viability of B. longum IPLA20022 is needed to exert the protective effect and that secreted factors seems to have anti-toxin activity.

Inhibitory potential of lactobacilli against Escherichia coli internalization by HT 29 cells

Adhesion and aggregation properties of Lactobacillaceae strains as protection ways against enteropathogenic bacteria

Ability of Lactobacillus to Inhibit Enteric Pathogenic Bacteria Adhesion on Caco-2 Cells

The adhesion of putative probiotic lactobacilli to cultured epithelial cells and porcine intestinal mucus

Inhibition of Bacterial Adhesion to Ht-29 Cells by Lipoteichoic Acid Extracted from Clostridium Butyricum

Several Strains of Lactic Acid Bacteria: Adhesion Ability to Caco-2 Cells and Effects on Adhesion of Pathogenic Bacteria

The adhesive characters of Lactobacillus to enterocyte-like HT-29 cells

Probiotic Properties of Lactobacilli and Their Ability to Inhibit the Adhesion of Enteropathogenic Bacteria to Caco-2 and HT-29 Cells

Ability of lactobacillus reuteri NCU801 to inhibit enteropathogens adhesion and invasion on caco-2 cells

Effect of Lactobacillus isolates on the adhesion of pathogens to chicken intestinal mucus in vitro.

<i>In vitro</i> evaluation of probiotic properties of <i>Lactobacillus acidophilus</i> AD125 and antagonism against <i>Escherichia coli</i> O157:H7 adhesion to Caco-2 cell

Screening of lactobacilli with antagonistic activity against enteroinvasive Escherichia coli

Inhibitory effects of reuterin on biofilm formation, quorum sensing and virulence genes of <i>Clostridium perfringens</i>

In Vitro Properties of Adhered to Caco-2 Cells of Lactobacillus Acidophilus and Bifidobacterium Bifidum and Their Antagonistic Activity Against Pathogen and Discuss Their Mechanisms

Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria.

Screening of Bifidobacteria and Lactobacilli Able to Antagonize the Cytotoxic Effect of Clostridium difficile upon Intestinal Epithelial HT29 Monolayer

Growth and adhesion inhibition of pathogenic bacteria by live and heat-killed food-origin Lactobacillus strains or their supernatants

Strain-specific probiotic properties of lactic acid bacteria and their interference with human intestinal pathogens invasion

Study of Adhesion Capability of Three Probiotics to HT-29 Cells andAdhesion Inhibition of Bacterial Pathogens

Internalization of Lactobacilus into Mice Intestine Peyer's Patches and Its Affect Factors

Identification of a Surface Protein from Lactobacillus Reuteri JCM1081 That Adheres to Porcine Gastric Mucin and Human Enterocyte-Like HT-29 Cells